PeerVoice Digestive Diseases Video: Recent Episodes
PeerVoice
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?
Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient
Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding
Teresa Tiano, Honours B.A. - A Challenging Journey: A Patient-Centred Perspective on Gastric Cancer
Ravi Ramjeesingh, MD, PhD, FRCPC - Immunotherapy for Biliary Tract Cancers: Changing the Narrative in Rare and Aggressive Tumours
Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line
Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy
Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment
Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC
Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools
John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Targeting IL-23 in Ulcerative Colitis: Can We Raise the Bar in Disease Control for Our Patients?
Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise
Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers
Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses
Gerald Prager, MD - Don't Leave a Drug on the Table: Maximising Use and Benefits of Later-Line Treatments for Advanced Colorectal Cancer
Brandon M. Meyers, MSc, MD, FRCPC - Raising the Bar in Advanced Hepatocellular Carcinoma Care: Insights to Optimize First-Line Treatment
David T. Rubin, MD, AGAF - What They Say and What They Think: Exploring Tools for Assessing Bowel Urgency in Patients with Ulcerative Colitis
Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?
Remo Panaccione, MD, FRCPC / Brian Bressler, MD, MS, FRCPC - It's About Time: Why We Need to Address Bowel Urgency in Patients With Ulcerative Colitis
John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Real-World Experience With Janus Kinase Inhibitors in the Treatment of Advanced Ulcerative Colitis: What Does the Evidence Say?
Bruno Sangro, MD, PhD - A New Era in the Management of Advanced HCC: Sequencing Therapies for the Second-Line and Beyond
Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency
Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Advanced Therapy for CPF in Crohn's: Evaluating the Evidence for Stem Cell Therapy and More
Perspectives on the Management of CPF: Moving the Goalposts With Shared Decision-Making
Gastric Cancer in the Crosshairs: The Evolving Role of Biomarkers and Targeted Therapy in Managing Advanced Gastric Cancer
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Shining a Light on the Treatment of Primary Hyperoxaluria 1: Does the Evidence Improve Our Options?
Applying Revised Treatment Guidelines for Advanced Hepatocellular Carcinoma: Considerations in Real-Life Practice
Hepatitis C in the Clinic: Case-Based Approaches to Identify and Manage Patients With HCV
Interpreting the Most Recent Clinical Data With A Real-World Lens: Implications on Hepatocellular Carcinoma Management
Are All Biologics the Same? Optimal Treatment Strategies for Patients With Inflammatory Bowel Disease
Suited to a T: Multidisciplinary Perspectives in Identifying and Targeting Key Subtypes of Peripheral T-Cell Lymphoma
Early Disease Control in Inflammatory Bowel Disease: Integrating the Latest Evidence for Better Outcomes
Making the Case for Personalized Management in mCSPC: Pertinent Characteristics to Choose the Right Therapy
Going Deep With Complex Perianal Fistulas in Crohn’s Disease: Analysing the Evidence for Stem-Cell Therapy
Building on the Pillars of IBD Treatment: Early Intervention, Treat-to-Target, and Tight Control
Understanding Patient-Reported Outcomes in Non-Metastatic Castration-Resistant Prostate Cancer to Optimize Treatment Selection
Staying Ahead of Perianal Fistulas in Crohn's Disease: A Focused Approach to Management
Gut Check: What New Therapies Mean for the Management of Pretreated, Metastatic Gastric Cancer
Optimizing Care of Patients With ADPKD in Primary Care: Expert Insights to Improve Patient Outcome
Changing Paradigms in Hematologic Malignancies: Translating Early Phase Evidence Into Clinical Practice
Maximising the Long-Term Treatment Plan for Unresectable Hepatocellular Carcinoma: A Sequential Approach to Improving Patient Outcomes
Exploring Treatment Choices in Crohn’s Disease: Using Current Evidence to Optimize Outcomes
An Integrative Approach to the Management of Spondyloarthritis: Improving Clinical Outcomes and Quality of Life